Next-generation sequencing (NGS) has transformed immune profiling, enabling deeper characterization of disease mechanisms, ...

The global clinical next-generation sequencing (NGS) market, valued at USD 6.2 billion in 2024, is expected to reach USD 15.2 billion by 2032 with a ...

By Hugo Francisco de Souza A landmark study harnesses long-read sequencing to reveal vast, previously undetected structural ...

Monoclonal antibodies are fundamental to modern biomedical research, therapeutic development, and diagnostic applications.

Lt. Col. M. Kelly Hourihan, director of the division’s Special Pathogens Clinical Diagnostic Laboratory, said the project successfully demonstrated the value of next-generation sequencing ...

The global companion diagnostics market is set to surge from USD 7.03 Billion in 2024 to USD 22.83 Billion by 2034, driven by rising cancer prevalence and precision medicine advancements. Key trends ...

The U.S. FDA has approved a new test for patients with lung cancer to match the correct individuals with a targeted treatment ...

Panelists discuss how biomarker development in anal cancer remains limited with PD-L1 status not influencing treatment ...

The Philippine Genome Center (PGC)-Visayas underscored the contribution of ‘next-generation sequencing’ in the field of ...